Trials / Completed
CompletedNCT06871072
Telerehabilitation for Multiple Sclerosis
Telerehabilitation for Multiple Sclerosis: Artificial Intelligence vs. Conventional Approaches in Strength Training. A Sin-gle-Blinded Randomized Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- University of Cadiz · Academic / Other
- Sex
- All
- Age
- 35 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Multiple sclerosis (MS) is a neurodegenerative disease affecting the central nervous system and is a leading cause of disability in young adults. It often produces strength deficits. Exercise has been shown to improve strength, mobility, and quality of life while reducing fatigue. Telerehabilitation offers a convenient, accessible alternative for MS patients. This study explores the use of an AI-powered application for prescribing and monitoring strength exercises, ensuring continuous feedback and adherence. Methods: Randomized clinical trial. Intervention of 3 weekly strength training ses-sions for 20 weeks, patients in the experimental group used the AI application, while patients in the control group followed the conventional method, paper-based exercises with access to videos.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Telerehabilitation | EG performed using an artificial intelli-gence (AI) application called RehBody, which detects body segments, assists in cor-recting the technique and monitoring the exercise, number of sets and repetitions done, and the adherence percentage |
| OTHER | Exercise program | CG participants followed the exercise program and trained at home with images and videos as support. |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2025-08-15
- Completion
- 2025-08-31
- First posted
- 2025-03-11
- Last updated
- 2025-09-19
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06871072. Inclusion in this directory is not an endorsement.